Parnax Lab Ltd () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Lactose (India)

Parnax Lab

Quest Laborato.

Denis Chem Lab

Transchem

Kimia Bioscien.

Tyche Industries

Bal Pharma

Krebs Biochem

Achyut Healthcar

Aptus Pharma

Why is Parnax Lab Ltd ?

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.32%

Positive results in Sep 25

OPERATING CF(Y) Highest at Rs 32.30 Cr
DEBT-EQUITY RATIO(HY) Lowest at 0.77 times
DEBTORS TURNOVER RATIO(HY) Highest at 6.52 times

With ROE of 12.3, it has a Attractive valuation with a 1.5 Price to Book Value

The stock is trading at a premium compared to its peers' average historical valuations
Over the past year, while the stock has generated a return of -32.83%, its profits have fallen by -6.6%

Majority shareholders : Promoters

Underperformed the market in the last 1 year

Even though the market (BSE500) has generated returns of 1.97% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -32.83% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Parnax Lab should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Parnax Lab for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Parnax Lab

-32.95%

-0.69

47.36%

Sensex

4.84%

0.40

11.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

17.11%

EBIT Growth (5y)

32.32%

Net Debt to Equity (avg)

0.77

Institutional Holding

ROE (avg)

12.32%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.53

EV to EBIT

10.91

EV to EBITDA

7.74

EV to Capital Employed

1.30

EV to Sales

1.00

PEG Ratio

Dividend Yield

ROCE (Latest)

11.97%

ROE (Latest)

12.26%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

RSI

No Signal

Bollinger Bands

Sideways

Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

OPERATING CF(Y)

Highest at Rs 32.30 Cr

DEBT-EQUITY RATIO(HY)

Lowest at 0.77 times

DEBTORS TURNOVER RATIO(HY)

Highest at 6.52 times

NET SALES(Q)

At Rs 62.60 cr has Grown at 31.1% (vs previous 4Q average

PBDIT(Q)

Highest at Rs 8.07 cr.

PBT LESS OI(Q)

Highest at Rs 4.57 cr.

PAT(Q)

Highest at Rs 3.63 cr.

EPS(Q)

Highest at Rs 3.16

-1What is not working for the Company

INTEREST(Q)

Highest at Rs 1.40 cr

Loading Valuation Snapshot...

Here's what is working for Parnax Lab

Operating Cash Flow - Annually

Highest at Rs 32.30 Cr

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (Rs Cr)

Net Sales - Quarterly

Highest at Rs 62.60 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly

At Rs 62.60 cr has Grown at 31.1% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 47.75 Cr

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly

Highest at Rs 8.07 cr.

in the last five quarters

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 4.57 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 3.63 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly

Highest at Rs 3.16

in the last five quarters

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)

Debt-Equity Ratio - Half Yearly

Lowest at 0.77 times

in the last five half yearly periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Debtors Turnover Ratio- Half Yearly

Highest at 6.52 times

in the last five half yearly periods

MOJO Watch

Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Parnax Lab

Interest - Quarterly

Highest at Rs 1.40 cr

in the last five quarters and Increased by 14.75 % (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)